University of Pittsburgh

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Pittsburgh sits in the top decile of US sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count).

1,238 total trials 160 currently recruiting 917 completed early-phase tilt top decile by trial count

University of Pittsburgh: 1,238 sponsored US clinical trials, 160 recruiting.

University of Pittsburgh sponsors 1,238 registered US clinical trials on ClinicalTrials.gov, 160 of them currently recruiting, and 917 completed. 84 of these trials are in Phase 3-4 (later-stage) and 160 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.

Top-decile sponsor footprint

University of Pittsburgh ranks in the top decile of sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 66/100

917 of 1,014 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,238 total, page 17 of 25

COMPLETED

Risk Factors and Potential Causes of Eustachian Tube Dysfunction in Adults

NCT01251432

COMPLETED Phase 2

Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention

NCT01487577

COMPLETED

Chemotherapy-induced Symptoms in Sarcoma Patients and the Impact of Tumor Burden

NCT01136824

COMPLETED Phase 2

Buprenorphine for Late-Life Treatment Resistant Depression

NCT01071538

COMPLETED Phase 4

ADAPT: Addressing Depression and Pain Together

NCT01124188

COMPLETED NA

Assessment of Digital Breast Tomosynthesis (DBT) in the Screening Environment

NCT01106911

TERMINATED NA

Cerebrospinal Fluid Pharmacokinetics of Daptomycin

NCT01025271

COMPLETED Phase 2

RCT of High- vs. Standard-Calorie Formula for Methadone-Exposed Infants

NCT02178189

COMPLETED NA

Self Management and Reminders With Technology: SMART Appraisal of an Integrated Personal Health Record (PHR)

NCT01078532

COMPLETED NA

Family Support Intervention in Intensive Care Units (The Four Supports Study)

NCT01107704

COMPLETED NA

Neurobiology of Sleep and Sleep Treatment Response in Returning Veterans

NCT01637584

COMPLETED Phase 2

Online Counseling to Enable Lifestyle-focused Obesity Treatment in Primary Care

NCT01044147

COMPLETED NA

Comparison of Two Exercise Interventions to Improve Gait in Older Persons

NCT01076413

COMPLETED Phase 2

Delivering an Evidence-Based Lifestyle Intervention Via the Internet: A Randomized Controlled Study

NCT01043718

COMPLETED Phase 2

Brief Intervention to Prevent Poor Psychosocial Outcomes in Living Donors

NCT01233700

COMPLETED

The Effect of Aromatase Inhibitors on Cardiovascular Risk Factors in Women With Breast Cancer

NCT01080170

COMPLETED NA

Functional Assessment Screening Tablets - Patient Reported Measures

NCT01080183

TERMINATED

Use of Fiber-optic Probe for Non-invasive Diagnosis of Melanoma and Assessment of Impact of Ultraviolet (UV) Exposure on Skin

NCT01085396

COMPLETED Phase 4

Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients

NCT00841971

COMPLETED NA

Haptoglobin Phenotype, Vitamin E and High-density Lipoprotein (HDL) Function in Type 1 Diabetes

NCT01098994

COMPLETED NA

Acute Pain Genomic Study

NCT01557751

COMPLETED Phase 2

Efficacy and Safety of IL-11 in DDAVP Unresponsive

NCT00994929

COMPLETED Phase 1

Oral L-Citrulline and ADMA in Pregnancy

NCT00743210

COMPLETED NA

The Effect of Exercise on Acute Nicotine Withdrawal

NCT01047930

COMPLETED NA

The Attitudes, Communication, Treatment and Support Intervention to Reduce Breast Cancer Treatment Disparity

NCT01184066

COMPLETED NA

Adherence and Health Effects of Video Dance in Postmenopausal Women

NCT01443455

COMPLETED

Use of Thermal and 3D Imaging to Quantify Arthritis

NCT01044823

TERMINATED NA

Study of Nutrition in Acute Pancreatitis

NCT00580749

COMPLETED NA

Treatment of Sleep Disturbances in Young Children With Autism

NCT01322022

COMPLETED

Antigen-Specific Cell Mediated Immune Response to Chlamydia Trachomatis

NCT00970749

COMPLETED NA

Optimizing NIPPV Use for Patients With ALS

NCT01035476

COMPLETED

Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing

NCT00978848

COMPLETED NA

Healthier Hearts and Brains in Treating Smoking: The HABITS Study

NCT00581464

COMPLETED NA

Reducing Depressive Symptoms in Systemic Lupus Erythematosus

NCT01120652

COMPLETED

Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1)

NCT01024673

COMPLETED NA

Prevention and Treatment of Voice Problems in Teachers

NCT01199172

COMPLETED

Investigation in Pregnancy Associate Cardiomyopathy

NCT01085955

COMPLETED NA

Evaluation Of "Coaching Boys Into Men" (CBIM) Program

NCT01367704

COMPLETED NA

A Study to Evaluate the Results of Facial Soft Tissue Reconstruction in Patients Who Have Suffered Traumatic Injury

NCT01345591

COMPLETED NA

Intervention to Reduce Dietary Sodium in Hemodialysis

NCT01125202

TERMINATED Early Phase 1

Pilot Study of IFN α2b for Melanoma Patients

NCT00871533

COMPLETED NA

Psychotherapy for Depressed Mothers of Psychiatrically Ill Children

NCT00919594

COMPLETED NA

Monitoring Organ Donors to Increase Transplantation Results (MOnIToR)

NCT00987714

COMPLETED Phase 4

Incomplete Response in Late Life Depression: Getting to Remission (IRL GREY)

NCT00892047

COMPLETED

Natural History of Amyloid Deposition in Adults With Down Syndrome

NCT01303133

COMPLETED

MR Imaging of Perinatal Brain Injury

NCT02008045

COMPLETED NA

Efficacy and Feasibility of a Personalized Treatment for Depression With Co-Occurring Anxiety

NCT00930293

COMPLETED NA

CO-OPerative Training for Stroke Rehabilitation

NCT02755805

TERMINATED Phase 1

Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer

NCT00907179

TERMINATED NA

Sleep and Endometrial Cancer

NCT00936598

← Previous Page 17 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 81
Phase 2 79
Phase 3 28
Phase 4 56

What is open in the University of Pittsburgh pipeline

160 recruiting of 1,238 indexed (13% open); 917 completed (74%).

Phase mix: 84 late (III/IV) vs 160 early (I/II) (early-phase heavy).

Top condition: Depression (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Pittsburgh: open-pipeline peers nationwide

Peers matched on 1,238 registered trials and 13% open enrollment, not the therapeutic-area sidebar.

University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20%22% Total trials Recruiting share University of PittsburghNorthwestern UniversityEmory UniversityUniversity of Colorado, DenverAstraZenecaIntermountain Health CareMcMaster UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Temple University
University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,238 trials (± recruiting share)

Sponsors near 13% open enrollment (± trial volume)

What to do with this University of Pittsburgh page

1,238 registered trials is a research-attention snapshot, not an endorsement of University of Pittsburgh or any single study.

  • 160 of University of Pittsburgh's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition University of Pittsburgh studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Pittsburgh pipeline card: 1,238 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.